# ARS Pharmaceuticals, Inc.: Form 8-K, filed Jan 13, 2025

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: 8-K
- Filed: 2025-01-13
- Accepted by EDGAR: Jan 13, 2025, 08:08 ET
- Period: 2025-01-13
- Accession: 0001193125-25-005014
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119312525005014/d910559d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119312525005014/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119312525005014/d910559d8k.htm

Filed Jan 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-005014. Last ingested by Listed: Oct 30, 2026, 16:39 ET. No prices; not investment advice.